11 July 2013
Mumbai, India.
Clinical trials by foreign pharmaceutical companies in India have slowed down due to new government rules that complicate testing for new drugs.
India's government implemented rules in January that impose a new approval process for trials and compensation packages for patients who fall sick or die during testing.
The Health Ministry signed the laws after it found in a probe last year that new drugs in some cases were being tested on patients without informing them. The probe was ordered by the Supreme Court after a nonprofit group in the central state of Madhya Pradesh complained.
Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ’Fair dealing’ or ’Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.
